Northern Trust Corp cut its holdings in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 12.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,270,024 shares of the company's stock after selling 334,053 shares during the period. Northern Trust Corp owned approximately 0.32% of Clarivate worth $11,532,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Clarkston Capital Partners LLC grew its position in shares of Clarivate by 8.1% in the 4th quarter. Clarkston Capital Partners LLC now owns 70,733,831 shares of the company's stock valued at $359,328,000 after purchasing an additional 5,319,535 shares during the period. Price T Rowe Associates Inc. MD lifted its position in Clarivate by 53.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock valued at $141,107,000 after acquiring an additional 9,691,104 shares in the last quarter. Thompson Siegel & Walmsley LLC boosted its stake in Clarivate by 14.4% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company's stock worth $53,333,000 after purchasing an additional 1,323,329 shares during the period. Perpetual Ltd increased its holdings in Clarivate by 24.6% during the 4th quarter. Perpetual Ltd now owns 9,192,680 shares of the company's stock worth $46,699,000 after purchasing an additional 1,816,936 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in shares of Clarivate by 6.6% in the 4th quarter. Vanguard Group Inc. now owns 8,750,858 shares of the company's stock valued at $44,454,000 after purchasing an additional 538,907 shares during the period. 85.72% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, Royal Bank of Canada reiterated a "sector perform" rating and set a $6.00 price objective on shares of Clarivate in a report on Thursday, February 20th.
Get Our Latest Stock Report on CLVT
Clarivate Stock Up 2.3%
Shares of NYSE:CLVT traded up $0.10 during trading on Tuesday, hitting $4.40. 4,794,000 shares of the company were exchanged, compared to its average volume of 5,245,957. Clarivate Plc has a fifty-two week low of $3.04 and a fifty-two week high of $7.15. The stock has a market cap of $3.01 billion, a price-to-earnings ratio of -4.58 and a beta of 1.49. The company has a current ratio of 0.87, a quick ratio of 0.88 and a debt-to-equity ratio of 0.88. The firm has a fifty day moving average price of $3.89 and a two-hundred day moving average price of $4.65.
Clarivate (NYSE:CLVT - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02. Clarivate had a negative net margin of 24.90% and a positive return on equity of 9.10%. The business had revenue of $593.70 million during the quarter, compared to analysts' expectations of $574.03 million. During the same period last year, the business earned $0.14 earnings per share. The firm's revenue was down 4.4% on a year-over-year basis. As a group, research analysts anticipate that Clarivate Plc will post 0.63 earnings per share for the current fiscal year.
Clarivate Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Read More

Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.